Terns Pharmaceuticals Stock Quote TERN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

10.57

Bid

10.56

Ask

10.58

Volume

792,694

10.25 Day's Range 10.6946

3.26 52 Week Range 11.40

Market Cap

743.831M

Previous Close

10.04

Open

10.28

Last Trade

10.5582

Last Trade Time

10:50:46

Financial Volume

$ 8,198,734

VWAP

10.3429

Average Volume (3m)

1,957,111

Shares Outstanding

70,371,911

Dividend Yield

PE Ratio

-8.21

Earnings Per Share (EPS)

-1.28

Revenue

Net Profit

-90.21M

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ternspharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TERN. The last closing price for Terns Pharmaceuticals was $10.04. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of $ 3.26 to $ 11.40.

Terns Pharmaceuticals currently has 70,371,911 shares outstanding. The market capitalization of Terns Pharmaceuticals is $706.53 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -8.21.

Overall Flow

Bullish

Net Premium

82k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

FOSTER CITY, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio...

Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity

Statistically significant mean weight loss up to 5.5% over 28 days (4.9% placebo adjusted) Well-tolerated with no treatment-related dose interruptions, reductions, or discontinuations even with...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.4	15.2671755725	9.17	10.7	8.56	2523837	9.54935799	CS
4	2.67	33.7974683544	7.9	11.4	6.98	3421125	9.52109865	CS
12	3.42	47.8321678322	7.15	11.4	6.41	1957111	8.7986667	CS
26	4.55	75.5813953488	6.02	11.4	4.32	1425689	7.87502614	CS
52	5.31	100.950570342	5.26	11.4	3.26	1047654	7.35088564	CS
156	0.32	3.12195121951	10.25	14.0435	1.45	561873	7.47005514	CS
260	-6.38	-37.6401179941	16.95	28.36	1.45	485922	7.93196612	CS

Symbol	Price	Vol.
XPONExpion360 Inc	$ 0.2181 (274.74%)	770.31M
BNZIBanzai International Inc	$ 6.3599 (120.83%)	41.46M
LFLYLeafly Holdings Inc	$ 2.7688 (54.68%)	22.29M
VERBVerb Technology Company Inc	$ 0.0769 (38.31%)	97.72M
AENTAlliance Entertainment Holding Corporation	$ 2.64 (29.41%)	3.34M
CRBPCorbus Pharmaceuticals Holdings Inc	$ 22.29 (-56.89%)	6.49M
LGCBLinkage Global Inc	$ 0.4546 (-54.03%)	1.08M
GSIWGarden Stage Ltd	$ 3.7225 (-52.46%)	4.61M
SKYESkye Bioscience Inc	$ 3.015 (-45.08%)	1.25M
KOPNKopin Corporation	$ 0.6475 (-32.84%)	5.9M
XPONExpion360 Inc	$ 0.2147 (268.90%)	768.89M
VERBVerb Technology Company Inc	$ 0.0766 (37.77%)	97.72M
NVDANVIDIA Corporation	$ 117.00 (-0.74%)	85.89M
SVMHSRIVARU Holding Ltd	$ 0.1239 (-0.08%)	58.16M
HOLOMicroCloud Hologram Inc	$ 0.254 (9.67%)	56.38M

Symbol

Price

Vol.